IP Library Granted Patent US 7,759,480
Granted Patent B2
US 7,759,480 · App. 11/668,174 · Granted Jul 20, 2010

Chloral-free DCA in oligonucleotide synthesis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,759,480
App. No.
11/668,174
Granted
Jul 20, 2010
Kind
B2
Abstract

A process of manufacturing oligonucleotides includes a 5′-deblocking step in which the 5-blocking group is removed with dichloroacetic acid that is essentially free of chloral. The process is useful for making oligonucleotides that are substantially free of chloral adducts.

Claims (16)

1. A process, comprising:

subjecting dichloroacetic acid comprising an initial concentration of chloral hydrate, chloral or a mixture thereof to distillation;

collecting at least one fraction of dichloroacetic acid, said fraction having a lower concentration of below about 0.03 weight % of chloral hydrate, chloral or a mixture thereof relative to said initial concentration; and

contacting an oligonucleotide comprising a blocked hydroxyl group with at least a portion of said at least one fraction of dichloroacetic acid under conditions suitable to remove said blocking group.

2. The process of claim 1 , wherein the lower concentration of chloral hydrate, chloral or a mixture thereof is below the limit of detection for chloral hydrate, chloral or a mixture thereof.

3. The process of claim 1 , wherein said blocked hydroxyl group comprises a 4,4′-dimethoxytrityl blocking group.

4. The process of claim 1 , wherein said blocked hydroxyl group is a blocked 5′-hydroxyl.

5. The process of claim 1 , wherein said distillation comprises vacuum distillation.

6. The process of claim 1 , whereby said deblocked oligonucleotide is provided substantially free of chloral hydrate, chloral or a mixture thereof.

7. The process of claim 1 , wherein the initial concentration of chloral hydrate, chloral or a mixture thereof and the lower concentration of chloral hydrate, chloral or a mixture thereof is detected by a chromatographic method.

8. The process of claim 7 , wherein said chromatographic method is high pressure liquid chromatography.

9. The process of claim 7 , wherein said chromatographic method is gas chromatography.

10. The process of claim 1 , wherein the oligonucleotide is bound to a solid support.

11. The process of claim 1 , wherein said dichloroacetic acid is present in the form of a dichloroacetic acid-containing solution.

12. The process of claim 11 , wherein the dichloroacetic acid-containing solution further comprises an arene solvent.

13. The process of claim 12 , wherein the arene solvent is toluene.

Assignments (1)
CHANGE OF NAME Recorded Jul 26, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 043341/0463 →